Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 8;24(9):8437.
doi: 10.3390/ijms24098437.

The Relationship between Insomnia and the Pathophysiology of Major Depressive Disorder: An Evaluation of a Broad Selection of Serum and Urine Biomarkers

Tina Drinčić  1 , Jens H van Dalfsen  1 , Jeanine Kamphuis  1 , Mike C Jentsch  1 , Sjoerd M van Belkum  1 , Marcus J M Meddens  2 , Brenda W J H Penninx  3 , Robert A Schoevers  1
Affiliations

The Relationship between Insomnia and the Pathophysiology of Major Depressive Disorder: An Evaluation of a Broad Selection of Serum and Urine Biomarkers

Tina Drinčić et al. Int J Mol Sci. .

Abstract

Insomnia exhibits a clinically relevant relationship with major depressive disorder (MDD). Increasing evidence suggests that insomnia is associated with neurobiological alterations that resemble the pathophysiology of MDD. However, research in a clinical population is limited. The present study, therefore, aimed to investigate the relationship between insomnia and the main pathophysiological mechanisms of MDD in a clinical sample of individuals with MDD. Data were extracted from three cohorts (N = 227) and included an evaluation of depression severity (Quick Inventory of Depressive Symptomatology, QIDS-SR16) and insomnia severity (QIDS-SR16 insomnia items) as well as serum and urine assessments of 24 immunologic (e.g., tumour necrosis factor α receptor 2 and calprotectin), neurotrophic (e.g., brain-derived neurotrophic factor and epidermal growth factor), neuroendocrine (e.g., cortisol and aldosterone), neuropeptide (i.e., substance P), and metabolic (e.g., leptin and acetyl-L-carnitine) biomarkers. Linear regression analyses evaluating the association between insomnia severity and biomarker levels were conducted with and without controlling for depression severity (M = 17.32), antidepressant use (18.9%), gender (59.0% female; 40.5% male), age (M = 42.04), and the cohort of origin. The results demonstrated no significant associations between insomnia severity and biomarker levels. In conclusion, for the included biomarkers, current findings reveal no contribution of insomnia to the clinical pathophysiology of MDD.

Keywords: biomarkers; insomnia; major depressive disorder; pathophysiology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Stewart R., Besset A., Bebbington P., Brugha T., Lindesay J., Jenkins R., Singleton N., Meltzer H. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep. 2006;29:1391–1397. doi: 10.1093/sleep/29.11.1391. - DOI - PubMed
    1. Troxel W.M., Kupfer D.J., Reynolds C.F., III, Frank E., Thase M.E., Miewald J.M., Buysse D.J. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations. J. Clin. Psychiatry. 2012;73:478–485. doi: 10.4088/JCP.11m07184. - DOI - PMC - PubMed
    1. Geoffroy P.A., Hoertel N., Etain B., Bellivier F., Delorme R., Limosin F., Peyre H. Insomnia and hypersomnia in major depressive episode: Prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study. J. Affect. Disord. 2018;226:132–141. doi: 10.1016/j.jad.2017.09.032. - DOI - PubMed
    1. Baglioni C., Battagliese G., Feige B., Spiegelhalder K., Nissen C., Voderholzer U., Lombardo C., Riemann D. Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. J. Affect. Disord. 2011;135:10–19. doi: 10.1016/j.jad.2011.01.011. - DOI - PubMed
    1. Hertenstein E., Feige B., Gmeiner T., Kienzler C., Spiegelhalder K., Johann A., Jansson-Fröjmark M., Palagini L., Rücker G., Riemann D., et al. Insomnia as a predictor of mental disorders: A systematic review and meta-analysis. Sleep Med. Rev. 2019;43:96–105. doi: 10.1016/j.smrv.2018.10.006. - DOI - PubMed